A multicenter cost-of-illness study on rheumatoid arthritis in Italy.

Abstract

In Italy, the indirect costs account for the highest cost for management of RA patients. Considering that costs increase with RA progression, the patients who show a rapid evolution of the functional damages should be identified early based on risk indicators.